Nesiritide: A Promising New Drug for the Treatment of Decompensated Heart Failure

Publisher： Karger

E-ISSN： 1424-0556|2|1|39-46

ISSN： 1422-9528

Source： Heart Drug, Vol.2, Iss.1, 2002-04, pp. : 39-46

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An update on nesiritide for treatment of decompensated heart failure

By Hobbs R.E.   Mills R.M.   Young J.B.  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 5, 2001-05 ,pp. : 935-942

Informa Healthcare

Access to resources Recommend Favorite

Benefit-Risk Assessment of Nesiritide in the Treatment of Acute Decompensated Heart Failure

By Yancy Clyde W.  

Drug Safety, Vol. 30, Iss. 9, 2007-01 ,pp. : 765-781

Adis International

Access to resources Recommend Favorite

Levosimendan: A New Inodilatory Drug for the Treatment of Decompensated Heart Failure

By  

Current Pharmaceutical Design, Vol. 11, Iss. 4, 2005-02 ,pp. : 435-455

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Treatment of Patients with Decompensated Heart Failure

By Mills R.M.   Hobbs R.E.  

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 2, 2001-01 ,pp. : 119-125

Adis International

Access to resources Recommend Favorite

Nesiritide for the treatment of congestive heart failure

By Iyengar Srinivas   Feldman David S   Trupp Robin   Abraham William T  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 4, 2004-04 ,pp. : 901-907

Informa Healthcare

Access to resources Recommend Favorite